Related Experiment Video
Updated: Sep 23, 2026

Workflow Based on the Combination of Isotopic Tracer Experiments to Investigate Microbial Metabolism of Multiple Nutrient Sources
Published on: January 22, 2018
Determination of CKMB activity and protein concentration and their application in the diagnosis of AMI
Insights
Measuring creatine kinase-MB (CKMB) protein levels identifies acute myocardial infarction (AMI) earlier than CKMB activity. Protein levels show distinct peak values, aiding earlier AMI diagnosis in patients.
Area of Science:
- Biochemistry
- Clinical Chemistry
- Cardiology
Background:
- Acute myocardial infarction (AMI) diagnosis relies on cardiac biomarker analysis.
- Creatine kinase-myocardial band (CKMB) is a key cardiac biomarker.
- Assessing CKMB activity and protein concentration aids in diagnosing myocardial damage.
Purpose of the Study:
- To compare the diagnostic utility of CKMB activity versus CKMB protein concentration for early AMI detection.
- To analyze the temporal profiles of CKMB activity and protein in AMI patients.
Main Methods:
- Enzyme activity and protein concentration of CKMB were measured.
- Samples were collected from 19 AMI patients, 17 non-AMI patients, and 26 healthy controls.
- Peak times and peak values of CKMB were analyzed.
Main Results:
- Peak times for CKMB activity and protein were similar in AMI and non-AMI patients.
- Peak values of CKMB protein concentration were significantly different compared to CKMB activity (F=50.1 vs F=5.3).
- CKMB protein levels demonstrated greater discriminative power between patient groups.
Conclusions:
- CKMB protein concentration measurement is a more sensitive and earlier indicator of AMI than CKMB activity.
- Protein level analysis offers a faster diagnostic window for acute myocardial infarction.
- This finding can improve the timely management of AMI patients.
Abstract:
The activity and protein concentration of CKMB in 19 patients with AMI, 17 non-AMI patients and 26 normal persons. It was found that both peak times in patients with AMI and non-AMI patients were similar but the peak values were different. At peak values the F value of CKMB (5.3) was much lower than that of CKMB protein concentration (50.1). We are led to conclude that the measurement of CKMB protein level can identify AMI much earlier than that of CKMB activity.
